BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Jonathan Douxfils; Hélène Haguet; Christian Chatelain; Carlos Graux; Jean-Michel Dogne

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Jonathan Douxfils, Hélène Haguet, Christian Chatelain, Carlos Graux, Jean-Michel Dogne

Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Blood - 2015 ASH Annual Meeting Abstracts
Pages	2785 - 2785
Number of pages	1
Volume	126
Publication status	E-pub ahead of print - 4 Dec 2015
Event	57th ASH Annual Meeting and Exposition - Orlando, United States Duration: 4 Dec 2015 → 8 Dec 2015

Conference

Conference	57th ASH Annual Meeting and Exposition
Country/Territory	United States
City	Orlando
Period	4/12/15 → 8/12/15

The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research

Cite this

@inproceedings{3e2384e458c8474e83adf2374fdad801,

title = "BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival",

author = "Jonathan Douxfils and H{\'e}l{\`e}ne Haguet and Christian Chatelain and Carlos Graux and Jean-Michel Dogne",

year = "2015",

month = dec,

day = "4",

language = "English",

volume = "126",

pages = "2785 -- 2785",

booktitle = "Blood - 2015 ASH Annual Meeting Abstracts",

note = "57th ASH Annual Meeting and Exposition ; Conference date: 04-12-2015 Through 08-12-2015",

}

Douxfils, J , Haguet, H , Chatelain, C , Graux, C & Dogne, J-M 2015, BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival. in Blood - 2015 ASH Annual Meeting Abstracts. vol. 126, pp. 2785 - 2785, 57th ASH Annual Meeting and Exposition, Orlando, Florida, United States, 4/12/15.

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival. / Douxfils, Jonathan ; Haguet, Hélène ; Chatelain, Christian et al.
Blood - 2015 ASH Annual Meeting Abstracts. Vol. 126 2015. p. 2785 - 2785.

Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

AU - Douxfils, Jonathan

AU - Haguet, Hélène

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Dogne, Jean-Michel

PY - 2015/12/4

Y1 - 2015/12/4

M3 - Conference contribution

VL - 126

SP - 2785

EP - 2785

BT - Blood - 2015 ASH Annual Meeting Abstracts

T2 - 57th ASH Annual Meeting and Exposition

Y2 - 4 December 2015 through 8 December 2015

ER -

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Conference

Projects

The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and

Cite this